Cargo Therapeutics Inc. has entered into a significant agreement with Dren Bio Management, Inc., as part of its strategic shift to suspend various development efforts and explore potential alternatives. The agreement involves an Assignment and Assumption of Lease, transferring all rights and obligations of Cargo's Lease Agreement for a property in San Carlos, California, to Dren Bio. The property spans approximately 99,557 square feet on the building's 3rd and 4th floors. Cargo Therapeutics has paid $35.8 million to the landlord, ARE San Francisco No. 63, LLC, to be released from further liability under the lease and an additional $567,474.90 to Dren Bio for a security deposit. The lease assignment, which includes a sublease with Vaxcyte Inc., is set to commence once certain conditions are met, with Dren Bio assuming responsibility for rent and associated charges. This development marks a pivotal step in Cargo's reevaluation of its strategic direction.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。